Etid klinik pou Migrèn nan Alabama
5 etid pou Migrèn ap chèche patisipan nan sit nan Alabama.
Vil nan Alabama
Tèks ofisyèl etid la (Anglè)
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Rehabilitation and Neurological Services /ID# 270782, Huntsville
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of Alabama at Birmingham Children's of Alabama, Birmingham
Ap rekrite
Laj 10 a 17 · Tout sèks · Mizajou Sep 21, 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rehabilitation & Neurological Services /ID# 229969, Huntsville
- The Center for Clinical Trials - Saraland /ID# 231546, Saraland
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Central Research Associates, LLC (CRA) dba Flourish Research, Birmingham
- AMR Mobile, Mobile
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Flourish - Birmingham, Birmingham
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou May 19, 2026 · NCT06602479Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.